Scadenza: 21 September 2021
Topic:
Proposals should cover all of the following activities:
- Development of a Strategic Research and Innovation Agenda (SRIA) for a comprehensive approach to inform the expected future European partnership on One Health antimicrobial resistance (OH AMR).
- Integration of key actors for AMR encompassing the field of human, veterinary and environmental disciplines and the broad spectrum of pathogens, including fungi and viruses.
- Robust communication and effective information exchange between diverse scientific disciplines and among multiple sectors of the society that are implicated such as patients, clinicians, veterinarians, pharmacists, food producers, pharmaceutical industry, policy makers and researchers (including those working in the social sciences and humanities).
Programma:
HORIZON-CSA HORIZON Coordination and Support Actions
Ente finanziatore:
EU
Budget complessivo:
1.00 million
Who can participate:
To be eligible for funding, applicants must be established in one of the eligible countries, i.e.:
– the Member States of the European Union, including their outermost regions;
– the Overseas Countries and Territories (OCTs) linked to the Member States9;
– eligible non-EU countries:
- countries associated to Horizon Europe
- low- and middle-income countries
Partnership: Mandatory
Status:
Closed
Quota finanziabile:
100%
Topic:
Proposals should cover all of the following activities:
- Development of a Strategic Research and Innovation Agenda (SRIA) for a comprehensive approach to inform the expected future European partnership on One Health antimicrobial resistance (OH AMR).
- Integration of key actors for AMR encompassing the field of human, veterinary and environmental disciplines and the broad spectrum of pathogens, including fungi and viruses.
- Robust communication and effective information exchange between diverse scientific disciplines and among multiple sectors of the society that are implicated such as patients, clinicians, veterinarians, pharmacists, food producers, pharmaceutical industry, policy makers and researchers (including those working in the social sciences and humanities).
Who can participate:
To be eligible for funding, applicants must be established in one of the eligible countries, i.e.:
– the Member States of the European Union, including their outermost regions;
– the Overseas Countries and Territories (OCTs) linked to the Member States9;
– eligible non-EU countries:
- countries associated to Horizon Europe
- low- and middle-income countries
Programme:
HORIZON-CSA HORIZON Coordination and Support Actions
Consortium: Required
Status: Open
Total budget:
1.00 million
Funding rate:
100%
Notes:
The Commission estimates that an EU contribution of around EUR 1.00 million would allow these outcomes to be addressed appropriately.
